Our studies focus on two ADAM17 substrates implicated in COPD pathogenesis: the IL‐6 cytokine receptor (IL6R) and the growth factor amphiregulin (AREG), one of the EGFR agonists produced by bronchial epithelial cells (Richter et al. This evidence concerns the gene IL6R and chronic obstructive pulmonary disease.